Alta DiagnoTech

Alta DiagnoTech operates as a diversified IVD player, offering products and services across the entire diagnostic value chain. Its portfolio is organized by technology (Molecular, Immuno, Biochemical, POCT), disease area (Infectious Disease, Cancer, Cardiovascular, etc.), and product type (Kits, Reagents, Instruments, Consumables). A key strategic pillar is its OEM and custom development service, providing end-to-end solutions from product development to manufacturing for client brands. The company serves both the clinical diagnostics market and the research community with 'Research Use Only' (RUO) products.

Provides a comprehensive suite of established in vitro diagnostic technologies including Molecular Diagnostics (PCR, Sequencing), Immunodiagnostics (ELISA, Chemiluminescence), Biochemical Diagnostics, and Point-of-Care Testing (POCT), coupled with full-service OEM and custom kit development capabilities.

Total raised: $10M

Competes with broad-line giants (Roche, Abbott, Siemens) and specialized firms (Qiagen, Bio-Rad) across IVD segments. Differentiates through an extensive product matrix across all major diagnostic technologies and a strong emphasis on integrated OEM and custom development services for client brands.